Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma - An Infrequent Event: Elucidation of Risk Factors and Management Implications
Antineoplastic Combined Chemotherapy Protocols
GRP is relatively uncommon but incurs significant morbidity. Potential risk factors include advanced-stage disease, along with smoking and alcohol consumption and possibly underlying lung disease. We recommend a high level of clinical alertness regarding the diagnosis, early pulmonary referral, and cessation of gemcitabine on suspicion of GRP.